{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:43:53Z","timestamp":1790045033013,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["No. NU20-03-00360"],"award-info":[{"award-number":["No. NU20-03-00360"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["No. NU20-03-00360"],"award-info":[{"award-number":["No. NU20-03-00360"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["No. NU20-03-00360"],"award-info":[{"award-number":["No. NU20-03-00360"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["No. NU20-03-00360"],"award-info":[{"award-number":["No. NU20-03-00360"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["No. NU20-03-00360"],"award-info":[{"award-number":["No. NU20-03-00360"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["No. NU20-03-00360"],"award-info":[{"award-number":["No. NU20-03-00360"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["No. NU20-03-00360"],"award-info":[{"award-number":["No. NU20-03-00360"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["No. NU20-03-00360"],"award-info":[{"award-number":["No. NU20-03-00360"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["No. NU20-03-00360"],"award-info":[{"award-number":["No. NU20-03-00360"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["No. NU20-03-00360"],"award-info":[{"award-number":["No. NU20-03-00360"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["No. NU20-03-00360"],"award-info":[{"award-number":["No. NU20-03-00360"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["No. NU20-03-00360"],"award-info":[{"award-number":["No. NU20-03-00360"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Glioblastoma is a malignant and aggressive type of central nevous system malignancy characterized by many distinct biological features including extensive hypoxia. Hypoxia in glioblatoma associates with complex signaling patterns including activation of several pathways such as MAPK, PI3K-AKT\/mTOR and IL-6\/JAK\/STAT3 with the master regulator HIF-1, which in turn drive particular tumor behaviors determining, in the end, treatment outcomes and patients fate. Thus, the present study was designed to investigate the expression of selected hypoxia related factors including STAT3 in a small set of long-term surviving glioma patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The expression of selected hypoxia related factors including STAT3 was evaluated in a time series of formalin fixed paraffin embedded and cryopreserved glioma samples from repeatedly resected patients. In addition, comparative studies were also conducted on primary glioma cells derived from original patient samples, stabilized glioma cell lines and tumor-xenograft mice model. Obtained data were correlated with clinical findings too.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Glioblastoma samples of the analyzed patients displayed heterogeneity in the expression of hypoxia- related and EMT markers with most interesting trend being observed in pSTAT3. This heterogeneity was subsequently confirmed in other employed models (primocultures derived from glioblastoma tissue resections, cryopreserved tumor specimens, stabilized glioblastoma cell line in vitro and in vivo) and concerned, in particular, STAT3 expression which remained stable. In addition, subsequent studies on the role of STAT3 in the context of glioblastoma hypoxia demonstrated opposing effects of its deletion on cell viability as well as the expression of hypoxia and EMT markers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results suport the importance of STAT3 expression and activity in the context of hypoxia in malignant glioblastoma long-term surviving glioma patients while emphasizing heterogeneity of biological outcomes in varying employed tumor models.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-024-12221-w","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T11:02:09Z","timestamp":1713870129000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients"],"prefix":"10.1186","volume":"24","author":[{"given":"Katerina","family":"Dvorakova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Skarkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"Vitovcova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Soukup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Vosmikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Pleskacova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Skarka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Christian","family":"Bartos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Krupa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Kasparova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Petera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"Rudolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,23]]},"reference":[{"issue":"6","key":"12221_CR1","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.5603\/RPOR.a2022.0113","volume":"27","author":"S Mohammed","year":"2022","unstructured":"Mohammed S, Dinesan M, Ajayakumar T. Survival and quality of life analysis in glioblastoma multiforme with adjuvant chemoradiotherapy: a retrospective study. Rep Pract Oncol Radiother. 2022;27(6):1026\u201336.","journal-title":"Rep Pract Oncol Radiother"},{"key":"12221_CR2","doi-asserted-by":"publisher","first-page":"112913","DOI":"10.1016\/j.ejca.2023.05.002","volume":"189","author":"C Hertler","year":"2023","unstructured":"Hertler C, Felsberg J, Gramatzki D, Le Rhun E, Clarke J, Soffietti R, Wick W, Chinot O, Ducray F, Roth P, et al. Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY brain Tumor Funders\u2019 Collaborative Consortium (EORTC 1419). Eur J Cancer. 2023;189:112913.","journal-title":"Eur J Cancer"},{"issue":"4","key":"12221_CR3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1615\/CritRevEukaryotGeneExpr.2015015601","volume":"25","author":"R Kalkan","year":"2015","unstructured":"Kalkan R. Hypoxia is the Driving Force behind GBM and could be a New Tool in GBM Treatment. Crit Rev Eukaryot Gene Expr. 2015;25(4):363\u20139.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"3","key":"12221_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.parint.2009.03.005","volume":"58","author":"AC Cumino","year":"2009","unstructured":"Cumino AC, Elissondo MC, Denegri GM. Flubendazole interferes with a wide spectrum of cell homeostatic mechanisms in Echinococcus Granulosus protoscoleces. Parasitol Int. 2009;58(3):270\u20137.","journal-title":"Parasitol Int"},{"key":"12221_CR5","doi-asserted-by":"crossref","unstructured":"Park JH, Lee HK. Current understanding of Hypoxia in Glioblastoma Multiforme and its response to Immunotherapy. Cancers (Basel) 2022, 14(5).","DOI":"10.3390\/cancers14051176"},{"key":"12221_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/HP.S93413","volume":"3","author":"B Muz","year":"2015","unstructured":"Muz B, de la Puente P, Azab F, Azab AK. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl). 2015;3:83\u201392.","journal-title":"Hypoxia (Auckl)"},{"issue":"1","key":"12221_CR7","doi-asserted-by":"publisher","first-page":"15195","DOI":"10.1038\/s41598-020-72290-2","volume":"10","author":"JJ Renfrow","year":"2020","unstructured":"Renfrow JJ, Soike MH, West JL, Ramkissoon SH, Metheny-Barlow L, Mott RT, Kittel CA, D\u2019Agostino RB Jr., Tatter SB, Laxton AW, et al. Attenuating hypoxia driven malignant behavior in glioblastoma with a novel hypoxia-inducible factor 2 alpha inhibitor. Sci Rep. 2020;10(1):15195.","journal-title":"Sci Rep"},{"issue":"7","key":"12221_CR8","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/j.ymthe.2018.05.004","volume":"26","author":"NL Downes","year":"2018","unstructured":"Downes NL, Laham-Karam N, Kaikkonen MU, Yla-Herttuala S. Differential but complementary HIF1alpha and HIF2alpha transcriptional regulation. Mol Ther. 2018;26(7):1735\u201345.","journal-title":"Mol Ther"},{"issue":"12","key":"12221_CR9","first-page":"22073","volume":"8","author":"Q Liu","year":"2015","unstructured":"Liu Q, Cao P. Clinical and prognostic significance of HIF-1alpha in glioma patients: a meta-analysis. Int J Clin Exp Med. 2015;8(12):22073\u201383.","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"12221_CR10","first-page":"5","volume":"4","author":"KR Luoto","year":"2013","unstructured":"Luoto KR, Kumareswaran R, Bristow RG. Tumor hypoxia as a driving force in genetic instability. Genome Integr. 2013;4(1):5.","journal-title":"Genome Integr"},{"issue":"3","key":"12221_CR11","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1158\/0008-5472.CAN-09-2715","volume":"70","author":"IM Pires","year":"2010","unstructured":"Pires IM, Bencokova Z, Milani M, Folkes LK, Li JL, Stratford MR, Harris AL, Hammond EM. Effects of acute versus chronic hypoxia on DNA damage responses and genomic instability. Cancer Res. 2010;70(3):925\u201335.","journal-title":"Cancer Res"},{"issue":"11","key":"12221_CR12","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/ni.2714","volume":"14","author":"AL Doedens","year":"2013","unstructured":"Doedens AL, Phan AT, Stradner MH, Fujimoto JK, Nguyen JV, Yang E, Johnson RS, Goldrath AW. Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen. Nat Immunol. 2013;14(11):1173\u201382.","journal-title":"Nat Immunol"},{"issue":"1","key":"12221_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, Han F, Du Y, Shi H, Zhou W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8(1):70.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"12221_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41598-017-18310-0","volume":"8","author":"N Beig","year":"2018","unstructured":"Beig N, Patel J, Prasanna P, Hill V, Gupta A, Correa R, Bera K, Singh S, Partovi S, Varadan V, et al. Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma. Sci Rep. 2018;8(1):7.","journal-title":"Sci Rep"},{"key":"12221_CR15","doi-asserted-by":"crossref","unstructured":"Skarkova V, Krupova M, Vitovcova B, Skarka A, Kasparova P, Krupa P, Kralova V, Rudolf E. The evaluation of Glioblastoma Cell Dissociation and its influence on its Behavior. Int J Mol Sci 2019, 20(18).","DOI":"10.3390\/ijms20184630"},{"issue":"2","key":"12221_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.yexcr.2018.05.032","volume":"369","author":"V Skarkova","year":"2018","unstructured":"Skarkova V, Kralova V, Krbal L, Matouskova P, Soukup J, Rudolf E. Oxaliplatin and irinotecan induce heterogenous changes in the EMT markers of metastasizing colorectal carcinoma cells. Exp Cell Res. 2018;369(2):295\u2013303.","journal-title":"Exp Cell Res"},{"issue":"20","key":"12221_CR17","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1093\/nar\/gni178","volume":"33","author":"C Chen","year":"2005","unstructured":"Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005;33(20):e179.","journal-title":"Nucleic Acids Res"},{"key":"12221_CR18","doi-asserted-by":"crossref","unstructured":"Soukup J, Gerykova L, Rachelkar A, Hornychova H, Bartos MC, Krupa P, Vitovcova B, Pleskacova Z, Kasparova P, Dvorakova K et al. Diagnostic utility of immunohistochemical detection of MEOX2, SOX11, INSM1 and EGFR in Gliomas. Diagnostics (Basel) 2023, 13(15).","DOI":"10.3390\/diagnostics13152546"},{"issue":"4","key":"12221_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00401-010-0645-6","volume":"119","author":"FE Bleeker","year":"2010","unstructured":"Bleeker FE, Atai NA, Lamba S, Jonker A, Rijkeboer D, Bosch KS, Tigchelaar W, Troost D, Vandertop WP, Bardelli A, Van Noorden CJ. The prognostic IDH1(R132) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma. Acta Neuropathol. 2010;119(4):487\u201394.","journal-title":"Acta Neuropathol"},{"issue":"7","key":"12221_CR20","doi-asserted-by":"publisher","first-page":"e0130596","DOI":"10.1371\/journal.pone.0130596","volume":"10","author":"A Amelot","year":"2015","unstructured":"Amelot A, De Cremoux P, Quillien V, Polivka M, Adle-Biassette H, Lehmann-Che J, Francoise L, Carpentier AF, George B, Mandonnet E, Froelich S. IDH-Mutation is a weak predictor of long-term survival in Glioblastoma patients. PLoS ONE. 2015;10(7):e0130596.","journal-title":"PLoS ONE"},{"issue":"3","key":"12221_CR21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00401-015-1427-y","volume":"130","author":"C Geisenberger","year":"2015","unstructured":"Geisenberger C, Mock A, Warta R, Rapp C, Schwager C, Korshunov A, Nied AK, Capper D, Brors B, Jungk C, et al. Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19\/20 co-gain. Acta Neuropathol. 2015;130(3):419\u201334.","journal-title":"Acta Neuropathol"},{"issue":"9","key":"12221_CR22","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/neuonc\/nou043","volume":"16","author":"NK Gerber","year":"2014","unstructured":"Gerber NK, Goenka A, Turcan S, Reyngold M, Makarov V, Kannan K, Beal K, Omuro A, Yamada Y, Gutin P, et al. Transcriptional diversity of long-term glioblastoma survivors. Neuro Oncol. 2014;16(9):1186\u201395.","journal-title":"Neuro Oncol"},{"key":"12221_CR23","doi-asserted-by":"publisher","first-page":"1218297","DOI":"10.3389\/fonc.2023.1218297","volume":"13","author":"JKH Spoor","year":"2023","unstructured":"Spoor JKH, den Braber M, Dirven CMF, Pennycuick A, Bartkova J, Bartek J, van Dis V, van den Bosch TPP, Leenstra S, Venkatesan S. Investigating chromosomal instability in long-term survivors with glioblastoma and grade 4 astrocytoma. Front Oncol. 2023;13:1218297.","journal-title":"Front Oncol"},{"issue":"1","key":"12221_CR24","doi-asserted-by":"publisher","first-page":"5993","DOI":"10.1038\/s41598-023-33047-9","volume":"13","author":"B Vitovcova","year":"2023","unstructured":"Vitovcova B, Skarkova V, Havelek R, Soukup J, Pande A, Caltova K, Rudolf E. Flubendazole exhibits anti-glioblastoma effect by inhibiting STAT3 and promoting cell cycle arrest. Sci Rep. 2023;13(1):5993.","journal-title":"Sci Rep"},{"issue":"6","key":"12221_CR25","first-page":"3141","volume":"7","author":"GS Lin","year":"2014","unstructured":"Lin GS, Chen YP, Lin ZX, Wang XF, Zheng ZQ, Chen L. STAT3 serine 727 phosphorylation influences clinical outcome in glioblastoma. Int J Clin Exp Pathol. 2014;7(6):3141\u20139.","journal-title":"Int J Clin Exp Pathol"},{"issue":"24","key":"12221_CR26","doi-asserted-by":"publisher","first-page":"8228","DOI":"10.1158\/1078-0432.CCR-08-1329","volume":"14","author":"M Abou-Ghazal","year":"2008","unstructured":"Abou-Ghazal M, Yang DS, Qiao W, Reina-Ortiz C, Wei J, Kong LY, Fuller GN, Hiraoka N, Priebe W, Sawaya R, Heimberger AB. The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas. Clin Cancer Res. 2008;14(24):8228\u201335.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"12221_CR27","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/neuonc\/now258","volume":"19","author":"N Colwell","year":"2017","unstructured":"Colwell N, Larion M, Giles AJ, Seldomridge AN, Sizdahkhani S, Gilbert MR, Park DM. Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells. Neuro Oncol. 2017;19(7):887\u201396.","journal-title":"Neuro Oncol"},{"issue":"36","key":"12221_CR28","doi-asserted-by":"publisher","first-page":"5552","DOI":"10.1038\/sj.onc.1208719","volume":"24","author":"Q Xu","year":"2005","unstructured":"Xu Q, Briggs J, Park S, Niu G, Kortylewski M, Zhang S, Gritsko T, Turkson J, Kay H, Semenza GL, et al. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene. 2005;24(36):5552\u201360.","journal-title":"Oncogene"},{"issue":"17","key":"12221_CR29","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1038\/sj.onc.1210031","volume":"26","author":"A Iwamaru","year":"2007","unstructured":"Iwamaru A, Szymanski S, Iwado E, Aoki H, Yokoyama T, Fokt I, Hess K, Conrad C, Madden T, Sawaya R, et al. A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo. Oncogene. 2007;26(17):2435\u201344.","journal-title":"Oncogene"},{"key":"12221_CR30","doi-asserted-by":"publisher","first-page":"1098482","DOI":"10.3389\/fcell.2023.1098482","volume":"11","author":"W Fu","year":"2023","unstructured":"Fu W, Hou X, Dong L, Hou W. Roles of STAT3 in the pathogenesis and treatment of glioblastoma. Front Cell Dev Biol. 2023;11:1098482.","journal-title":"Front Cell Dev Biol"},{"issue":"354","key":"12221_CR31","doi-asserted-by":"publisher","first-page":"354re353","DOI":"10.1126\/scitranslmed.aaf6853","volume":"8","author":"M Allen","year":"2016","unstructured":"Allen M, Bjerke M, Edlund H, Nelander S, Westermark B. Origin of the U87MG glioma cell line: good news and bad news. Sci Transl Med. 2016;8(354):354re353.","journal-title":"Sci Transl Med"},{"key":"12221_CR32","doi-asserted-by":"crossref","unstructured":"Pokorna M, Hudec M, Jurickova I, Vacha M, Polivkova Z, Kutna V, Pala J, Ovsepian SV, Cerna M. O\u2019Leary VB: All-Trans Retinoic Acid Fosters the Multifarious U87MG Cell Line as a Model of Glioblastoma. Brain Sci 2021, 11(6).","DOI":"10.3390\/brainsci11060812"},{"issue":"11","key":"12221_CR33","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/s41419-018-1176-7","volume":"9","author":"X Ge","year":"2018","unstructured":"Ge X, Pan MH, Wang L, Li W, Jiang C, He J, Abouzid K, Liu LZ, Shi Z, Jiang BH. Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a\/Bad\/Bax axis. Cell Death Dis. 2018;9(11):1128.","journal-title":"Cell Death Dis"},{"issue":"18","key":"12221_CR34","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1097\/WNR.0000000000001156","volume":"29","author":"W Huang","year":"2018","unstructured":"Huang W, Ding X, Ye H, Wang J, Shao J, Huang T. Hypoxia enhances the migration and invasion of human glioblastoma U87 cells through PI3K\/Akt\/mTOR\/HIF-1alpha pathway. NeuroReport. 2018;29(18):1578\u201385.","journal-title":"NeuroReport"},{"key":"12221_CR35","doi-asserted-by":"crossref","unstructured":"Bronisz A, Salinska E, Chiocca EA, Godlewski J. Hypoxic Roadmap of Glioblastoma-learning about directions and distances in the Brain Tumor Environment. Cancers (Basel) 2020, 12(5).","DOI":"10.3390\/cancers12051213"},{"issue":"10","key":"12221_CR36","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.2967\/jnumed.120.249524","volume":"62","author":"S Collet","year":"2021","unstructured":"Collet S, Guillamo JS, Berro DH, Chakhoyan A, Constans JM, Lechapt-Zalcman E, Derlon JM, Hatt M, Visvikis D, Guillouet S, et al. Simultaneous mapping of vasculature, Hypoxia, and Proliferation using dynamic susceptibility contrast MRI, (18)F-FMISO PET, and (18)F-FLT PET in relation to contrast enhancement in newly diagnosed Glioblastoma. J Nucl Med. 2021;62(10):1349\u201356.","journal-title":"J Nucl Med"},{"issue":"1","key":"12221_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ccr.2006.11.020","volume":"11","author":"C Calabrese","year":"2007","unstructured":"Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, Oh EY, Gaber MW, Finklestein D, Allen M, et al. A perivascular niche for brain tumor stem cells. Cancer Cell. 2007;11(1):69\u201382.","journal-title":"Cancer Cell"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12221-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12221-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12221-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T11:03:51Z","timestamp":1713870231000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12221-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12221"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12221-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,23]]},"assertion":[{"value":"22 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by Ethics committee, University Hospital Hradec Kralove (Reference No. 201906 S26P) and all patients gave their written informed consent. The animal part study was carried out in line with principles of the Declaration of Helsinki and the approval was granted by the Animal welfare body of Faculty of Medicine in Hradec Kralove with final confirmation of Ministry of Education, Youth and Sports Czech Republic, project number: MSMT- 18525\/2021-3. The study is reported in accordance with ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"509"}}